Hepatology

A new model predicts HCC risk in noncirrhotic CHB patients, focusing on HBV DNA levels and other key factors.

A clinical trial was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.

Data from 22 studies, encompassing 756,088 subjects, including 62,072 Hispanic adults, revealed striking findings.

Alcohol consumption exacerbates the risk of cirrhosis and hepatocellular carcinoma, promoting hepatitis B virus replication and weakening immunity.

Inflammatory and oxidative processes underpin the connection between high Haemoglobin Glycation Index and disease progression.

Lifestyle interventions, particularly achieving a weight loss of over 10%, have been shown to resolve MASH.

A 96-week study finds bulevirtide safe and effective for HDV-related cirrhosis, improving liver health and reducing complications.

Low donor fasting glucose predicts poorer outcomes after LDLT, highlighting its potential as a prognostic marker.